Phototherapy Equipment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End-use, By Region & Competition, 2021-2031F

The global phototherapy equipment market is projected to expand from USD 491.01 Million in 2025 to USD 672.42 Million by 2031, exhibiting a compound annual growth rate of 5.38%. These medical devices use specific light wavelengths, including ultraviolet and fluorescent sources, to treat various dermatological conditions like psoriasis, vitiligo, and neonatal jaundice. This market growth is primarily driven by the increasing prevalence of chronic skin conditions and the crucial need for effective, non-invasive therapies, especially for infants. Additionally, the increasing demand for economical treatment options, serving as alternatives to systemic medications, further boosts the adoption of phototherapy devices in both clinical and home care environments. However, a key challenge for the market involves the potential long-term safety concerns linked to ultraviolet radiation exposure, such as erythema and the risk of skin malignancy, which could reduce patient compliance. Despite a significant patient pool, with psoriasis affecting an estimated 3.0 percent of U.S. adults in 2025, as reported by the American Academy of Dermatology, these safety apprehensions hinder the wider adoption of phototherapy solutions, despite their critical necessity.

Market Driver

A primary driver for the Global Phototherapy Equipment Market is the increasing global incidence of chronic dermatological conditions. The growing prevalence of autoimmune disorders such as atopic dermatitis and psoriasis elevates the dependence on phototherapy as an essential non-pharmacological treatment. With atopic dermatitis affecting an estimated 204 million people worldwide by February 2025, as reported by the International League of Dermatological Societies in the Skin Allergy Journal, a substantial patient demographic fuels the ongoing demand for phototherapy units in dermatology clinics for managing disease flare-ups. Furthermore, the market potential is amplified by the significant number of patients with uncontrolled conditions, evidenced by National Psoriasis Foundation data from January 2025 showing that 79.3 percent of psoriasis patients were not in remission, highlighting the critical need for effective therapies like light therapy to enhance clinical results. Concurrently, greater awareness among healthcare professionals regarding phototherapy's effectiveness is driving increased utilization of advanced equipment. Dermatologists are increasingly favoring targeted light treatments due to their favorable safety profile and efficacy compared to systemic medications, which boosts device productivity. This trend is corroborated by performance data from key technology providers; for instance, Strata Skin Sciences reported in March 2025 that the average net revenue per domestic XTRAC system rose to $5,906 in Q4 2024, marking a 6 percent year-over-year increase. Such figures demonstrate that as clinicians recognize the therapeutic advantages, the usage intensity of existing phototherapy infrastructure increases, thereby enhancing market value and fostering broader adoption.

Market Challenge

A significant restraint for the phototherapy equipment market stems from the potential long-term safety risks linked to ultraviolet radiation exposure. Clinical worries about side effects, particularly erythema and an increased risk of skin malignancy, lead to reluctance among both healthcare providers and patients. This apprehension directly influences the adoption rates of phototherapy devices, as patients frequently prefer to avoid treatments that might worsen their existing health concerns. As a result, the growing preference for biological drugs or other systemic alternatives that bypass radiation exposure establishes a competitive hurdle for device manufacturers. Regulatory authorities and medical organizations consistently highlight the connection between cumulative UV exposure and skin damage, which further impedes market growth. This risk is supported by current health data on skin pathologies; for example, the Skin Cancer Foundation estimated 200,340 melanoma cases were diagnosed in the United States in 2024. These statistics underscore the need for stringent safety protocols in phototherapy, subsequently increasing the administrative load on clinics and restricting the broad application of these devices for managing chronic skin conditions.

Market Trends

The increasing availability of home-based treatment solutions is shifting healthcare delivery from clinical settings to domestic environments. This trend is fueled by the creation of portable, user-friendly devices that enable patients to privately manage chronic conditions such as psoriasis, thereby reducing the necessity for frequent clinic visits. This transition is strongly supported by recent clinical data indicating that the effectiveness of remote treatment is comparable to in-office procedures. For instance, the American Academy of Dermatology's 'Light Treatment Effectiveness (LITE) study' in March 2024 reported that 32.8 percent of patients undergoing home phototherapy achieved clear or almost clear skin within 12 weeks, surpassing the 25.6 percent seen in those receiving office-based treatments. This evidence of non-inferiority is accelerating the broader acceptance of home units as a primary therapeutic choice. Concurrently, the market is broadening its focus beyond conventional medical pathology to include aesthetic and acne treatment applications. Manufacturers are increasingly commercializing devices tailored for cosmetic concerns, thereby reaching a wider patient base interested in non-invasive skin rejuvenation and effective management of active acne. This diversification is clearly demonstrated by the commercial expansion of specialized technologies that integrate medical dermatology with aesthetics. As reported by Strata Skin Sciences in May 2024, the installed base of its proprietary TheraClear(R)X photo-pneumatic acne treatment system exceeded 100 units domestically, showcasing the growing market demand for adaptable phototherapy solutions that offer aesthetic benefits.

Key Market Players

• Signify Holding
• GE Healthcare
• Natus Medical Incorporated
• Hebert Waldmann GmbH & Co. KG
• Nice Neotech Medical Systems Pvt. Ltd.
• Atom Medical Corporation
• Phoenix Medical Systems Pvt. Ltd.
• National Biological Corp.
• Solarc Systems Inc.
• The Daavlin Company

Report Scope

In this report, the Global Phototherapy Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Phototherapy Equipment Market, By Product

• Conventional Phototherapy Equipment
• LED Phototherapy Equipment
• Fiber Optic Phototherapy Equipment

Phototherapy Equipment Market, By Application

• Skin Diseases Treatment
• Psoriasis
• Vitiligo
• Eczema
• others

Phototherapy Equipment Market, By End-use

• Hospitals & Clinics
• Homecare
• Others

Phototherapy Equipment Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Phototherapy Equipment Market.

Available Customizations:

Global Phototherapy Equipment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).